SM
ZBH icon

SG3 Management’s Zimmer Biomet ZBH Stock Holding History

SG3 Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,300
Closed -$2.34M – 900
2022
Q1 		$2.34M Buy
+18,300
New +$2.21M 0.07% 270
2021
Q4 		– Sell
-10,300
Closed -$1.46M – 1327
2021
Q3 		$1.46M Buy
+10,300
New +$1.52M 0.04% 377

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SG3 Management's ZBH Position: Q3 2021 in Review

SG3 Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 2,060 shares — an estimated $303K sold.

SG3 Management first reported a position in ZBH in Q2 2020 and held it in 3 quarters. The position peaked at $322K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • SG3 Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • SG3 Management sold 2,060 Zimmer Biomet shares in Q3 2021, an estimated $303K.
  • SG3 Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 3 quarters.
  • SG3 Management's Zimmer Biomet position peaked at $322K in Q2 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.